Pascal Druzgala

Pascal Druzgala appears in our data through filings on ARYx Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 13 November 2007 to 17 August 2009, the count stands at 5 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 19 August 2009 came the latest disclosure, a transaction in ARYx Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.